Enrique Grande argues that in high-grade NMIBC, a surgeon-led, guideline-adherent pathway starting at first TURBT is linked to better long-term oncologic outcomes, emphasizing care delivery quality over drug choice alone.
In high-grade NMIBC, outcomes are not only about treatment choice—but about how care is delivered from the very beginning.
A surgeon-led, guideline-adherent pathway from first TURBT is associated with significantly better long-term oncological outcomes.
Quality of care
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare